Anke Nijhuis

987 total citations
18 papers, 661 citations indexed

About

Anke Nijhuis is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Anke Nijhuis has authored 18 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Anke Nijhuis's work include Inflammatory Bowel Disease (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and IL-33, ST2, and ILC Pathways (2 papers). Anke Nijhuis is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and IL-33, ST2, and ILC Pathways (2 papers). Anke Nijhuis collaborates with scholars based in United Kingdom, Italy and Spain. Anke Nijhuis's co-authors include Andrew Silver, James O. Lindsay, Shameer Mehta, Hector C. Keun, Roger Feakins, Tomoko Kumagai, Amy Lewis, Rosemary Jeffery, Cleo L. Bishop and Richard Poulsom and has published in prestigious journals such as Molecular Cell, JNCI Journal of the National Cancer Institute and Gut.

In The Last Decade

Anke Nijhuis

18 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anke Nijhuis United Kingdom	14	324	218	209	121	101	18	661
Torunn Bruland Norway	15	238 0.7×	145 0.7×	87 0.4×	191 1.6×	124 1.2×	39	596
Brian Hurwitz United States	10	576 1.8×	120 0.6×	289 1.4×	110 0.9×	148 1.5×	11	889
Huihui Chen China	15	312 1.0×	97 0.4×	160 0.8×	83 0.7×	182 1.8×	43	626
Fanny Daniel France	9	298 0.9×	176 0.8×	209 1.0×	128 1.1×	52 0.5×	14	610
Haisheng Zhou China	15	522 1.6×	108 0.5×	199 1.0×	198 1.6×	165 1.6×	31	964
Mark Baugh United Kingdom	8	184 0.6×	159 0.7×	128 0.6×	90 0.7×	110 1.1×	9	518
Ahmed Atef Ibrahim United States	11	284 0.9×	139 0.6×	95 0.5×	65 0.5×	138 1.4×	19	540
Manon de Ladurantaye Canada	13	265 0.8×	80 0.4×	129 0.6×	77 0.6×	156 1.5×	17	574

Countries citing papers authored by Anke Nijhuis

Since Specialization

Citations

This map shows the geographic impact of Anke Nijhuis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Nijhuis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Nijhuis more than expected).

Fields of papers citing papers by Anke Nijhuis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke Nijhuis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Nijhuis. The network helps show where Anke Nijhuis may publish in the future.

Co-authorship network of co-authors of Anke Nijhuis

This figure shows the co-authorship network connecting the top 25 collaborators of Anke Nijhuis. A scholar is included among the top collaborators of Anke Nijhuis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke Nijhuis. Anke Nijhuis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

McNeish, Iain A., et al.. (2023). Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma. Cell Reports. 42(10). 113307–113307. 18 indexed citations

Keun, Hector C. & Anke Nijhuis. (2023). RBM39: A druggable metabolic sensor linking RNA splicing, transcriptional regulation, and metabolic reprogramming in cancer. Molecular Cell. 83(23). 4202–4204. 3 indexed citations

Lewis, Amy, Anke Nijhuis, Shameer Mehta, et al.. (2022). Small-molecule Wnt inhibitors are a potential novel therapy for intestinal fibrosis in Crohns disease. Clinical Science. 136(19). 1405–1423. 16 indexed citations

Benito, Adrián, et al.. (2020). Lactic acidosis induces resistance to the pan-Akt inhibitor uprosertib in colon cancer cells. British Journal of Cancer. 122(9). 1298–1308. 32 indexed citations

Nijhuis, Anke, et al.. (2020). RNA‐binding motif protein 39 (RBM39): An emerging cancer target. British Journal of Pharmacology. 179(12). 2795–2812. 58 indexed citations

Lewis, Amy, Anke Nijhuis, Cleo L. Bishop, et al.. (2019). P035 Pharmacological inhibition of the canonical WNT signalling pathway represents a potential novel therapy for fibrosis in Crohn’s disease. Journal of Crohn s and Colitis. 13(Supplement_1). S103–S104. 3 indexed citations

Mehta, Shameer, Amy Lewis, Anke Nijhuis, et al.. (2018). Epithelial down‐regulation of the miR‐200 family in fibrostenosing Crohn's disease is associated with features of epithelial to mesenchymal transition. Journal of Cellular and Molecular Medicine. 22(11). 5617–5628. 26 indexed citations

Nijhuis, Anke, Renata Curciarello, Shameer Mehta, et al.. (2017). MCL-1 is modulated in Crohn’s disease fibrosis by miR-29b via IL-6 and IL-8. Cell and Tissue Research. 368(2). 325–335. 30 indexed citations

Nijhuis, Anke, Harry Harvey, Richard Poulsom, et al.. (2017). GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions. Oncotarget. 8(48). 84258–84275. 46 indexed citations

10.

Nijhuis, Anke, Julie Adam, Luke Gammon, et al.. (2017). Remodelling of microRNAs in colorectal cancer by hypoxia alters metabolism profiles and 5-fluorouracil resistance. Human Molecular Genetics. 26(8). 1552–1564. 49 indexed citations

11.

Santoro, Valeria, Anke Nijhuis, Rosemary Jeffery, et al.. (2015). Role of Reactive Oxygen Species in the Abrogation of Oxaliplatin Activity by Cetuximab in Colorectal Cancer. JNCI Journal of the National Cancer Institute. 108(6). djv394–djv394. 46 indexed citations

12.

Lewis, Amy, Shameer Mehta, Rosemary Jeffery, et al.. (2015). Low Serum Levels of MicroRNA-19 Are Associated with a Stricturing Crohnʼs Disease Phenotype. Inflammatory Bowel Diseases. 21(8). 1926–1934. 52 indexed citations

13.

Lewis, Amy, Anke Nijhuis, Shameer Mehta, et al.. (2015). Intestinal Fibrosis in Crohnʼs Disease. Inflammatory Bowel Diseases. 21(5). 1141–1150. 30 indexed citations

14.

MacFie, Tammie S., Richard Poulsom, Gary Warnes, et al.. (2014). DUOX2 and DUOXA2 Form the Predominant Enzyme System Capable of Producing the Reactive Oxygen Species H2O2 in Active Ulcerative Colitis and are Modulated by 5-Aminosalicylic Acid. Inflammatory Bowel Diseases. 20(3). 514–524. 81 indexed citations

15.

Mehta, Shameer, Anke Nijhuis, Tomoko Kumagai, James O. Lindsay, & Andrew Silver. (2014). Defects in the adherens junction complex (E-cadherin/ β-catenin) in inflammatory bowel disease. Cell and Tissue Research. 360(3). 749–760. 80 indexed citations

16.

Nijhuis, Anke, Paolo Biancheri, Amy Lewis, et al.. (2014). In Crohn's disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts. Clinical Science. 127(5). 341–350. 86 indexed citations

17.

Biancheri, Paolo, Anke Nijhuis, Antonio Di Sabatino, et al.. (2013). P057 Micro-RNA expression profiling identifies miR-29b as a relevant pro-fibrogenic factor in Crohn's disease intestinal strictures. Journal of Crohn s and Colitis. 7. S32–S32. 2 indexed citations

18.

MacFie, Tammie S., Alexandra Parker, Anke Nijhuis, et al.. (2012). PWE-255 5-ASA enhances DUOX2 expression in active ulcerative colitis: a risk for colorectal cancer?. Gut. 61(Suppl 2). A401.2–A402. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact